dermatology

LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
LEO Pharma and PellePharm Announce Collaboration to Advance Rare Skin Disease Therapies Worth up to $760 Million
CP Wire
LEO Pharma
PellePharm
Gorlin Syndrome
dermatology
Flag link:
Lilly CMO Robert Brown to lead Brickell Bio as it eyes phase 3 dermatology trials
Lilly CMO Robert Brown to lead Brickell Bio as it eyes phase 3 dermatology trials
Fierce Biotech
Brickell Bio
Eli Lilly
Robert Brown
dermatology
Flag link:
Novartis sells parts of Sandoz for $1bn
Novartis sells parts of Sandoz for $1bn
Pharmaforum
Novartis
Sandoz
M&A
dermatology
Aurobindo
Flag link:
Allergan preludes major selloffs with $650M Almirall dermatology sale
Allergan preludes major selloffs with $650M Almirall dermatology sale
Fierce Pharma
Allergan
dermatology
Almirall
M&A
Flag link:
Bayer sells prescription dermatology brands to Denmark's Leo Pharma
Bayer sells prescription dermatology brands to Denmark's Leo Pharma
Reuters
Bayer
LEO Pharma
dermatology
M&A
Flag link:
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
GoinPharma
Novartis
dermatology
generics
M&A
Aurobindo
Shanghai Fosun Pharmaceutical
Apollo Global Management
Flag link:
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Aurobindo
Novartis
Sandoz
M&A
dermatology
India
Flag link:
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Seasoned reps could help Aclaris' Eskata with a pleasantly surprising launch: analyst
Fierce Pharma
drug reps
dermatology
Aclaris
Eskata
drug launches
seborrheic keratoses
Flag link:
Novartis Weighs Sale of Dermatology Generics Business
Novartis Weighs Sale of Dermatology Generics Business
Bloomberg
Novartis
dermatology
M&A
Flag link:
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Endpoints
R&D
layoffs
Galderma
Nestle
dermatology
Flag link:
5 Reasons Valeant's Situation Could Get Worse
5 Reasons Valeant's Situation Could Get Worse
Motley Fool
Valeant Pharmaceuticals
LOEs
dermatology
debt
Flag link:
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Novartis bags a new eczema drug, builds dermatology pipeline with Ziarco buyout
Endpoints
Novartis
eczema
dermatology
M&A
ZPL389
Ziarco
Flag link:
Mylan, Lupin, others now in the mix for $1.1B Bayer derm buy
Mylan, Lupin, others now in the mix for $1.1B Bayer derm buy
Fierce Pharma
Mylan Labs
Lupin
Bayer
dermatology
M&A
Cadila
Torrent Pharmaceuticals
Flag link:
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Teva, Perrigo and Sun join list of suitors checking out Bayer's $1.1B derm unit
Fierce Pharma
Teva Pharmaceutical
Perrigo
Sun Pharma
Bayer
dermatology
M&A
Flag link:
Bayer eyes $1B-plus dermatology sale to fund Monsanto quest
Bayer eyes $1B-plus dermatology sale to fund Monsanto quest
Fierce Pharma
Bayer
dermatology
Monsanto
M&A
Flag link:
Valeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News?
Valeant Pharmaceuticals Intl Inc (VRX) May Have A Buyer For Derma Assets; Finally Some Good News?
Bidness, ETC
Valeant Pharmaceuticals
dermatology
M&A
Almirall
Spain
Flag link:
AstraZeneca sells off dermatology drug rights to LEO Pharma
AstraZeneca sells off dermatology drug rights to LEO Pharma
BioPharma Dive
AstraZeneca
dermatology
LEO Pharma
M&A
Flag link:
Valeant Pharmaceuticals Intl Inc (VRX) Stock Drops on Sale of Dermatology Assets
Valeant Pharmaceuticals Intl Inc (VRX) Stock Drops on Sale of Dermatology Assets
Bidness, ETC
Valeant Pharmaceuticals
dermatology
M&A
Solta
Obagi Medical Products
Flag link:
Valeant Pharmaceuticals' 2016 Outlook Blemished by Continued Dermatology Woes
Valeant Pharmaceuticals' 2016 Outlook Blemished by Continued Dermatology Woes
Motley Fool
Valeant Pharmaceuticals
dermatology
opthalmology
Flag link:
Mylan NV Expands Dermatology Business with $1 Billion Renaissance Acquisition: A Smart Move?
Mylan NV Expands Dermatology Business with $1 Billion Renaissance Acquisition: A Smart Move?
Bidness, ETC
Mylan Labs
dermatology
M&A
generics
Renaissance Acquisition Holdings
Flag link:

Pages